Copyright
©The Author(s) 2020.
World J Clin Cases. Dec 26, 2020; 8(24): 6529-6536
Published online Dec 26, 2020. doi: 10.12998/wjcc.v8.i24.6529
Published online Dec 26, 2020. doi: 10.12998/wjcc.v8.i24.6529
Antibiotics | Result | Sensitivity | Method | Breakpoint | |
S | R | ||||
Ampicillin | ≥ 32 | R | MIC | ≤ 8 | ≥ 32 |
Ampicillin/sulbactam | ≥ 32 | R | MIC | ≤ 8 | ≥ 32 |
Ticarcillin | ≥ 128 | R | MIC | ≤ 16 | ≥ 128 |
Ticacillin/clavulanic acid | ≥ 128 | R | MIC | ≤ 16 | ≥ 128 |
Piperacillin | ≥ 128 | R | MIC | ≤ 16 | ≥ 128 |
Piperacillin/tazobactam | ≥ 128 | R | MIC | ≤ 16 | ≥ 128 |
Cefuroxime | ≥ 64 | R | MIC | ≤ 8 | ≥ 32 |
Cefazolin | ≥ 64 | R | MIC | ≤ 2 | ≥ 8 |
Cefalotin | ≥ 64 | R | MIC | ≤ 8 | ≥ 32 |
Ceftazidime | 1 | S | MIC | ≤ 4 | ≥ 16 |
Ceftazidime/avibatan | 21 | S | K-B | ≥ 21 | ≤ 20 |
Cefotaxime | ≥ 64 | R | MIC | ≤ 1 | ≥ 4 |
Ceftriaxone | ≥ 64 | R | MIC | ≤ 1 | ≥ 4 |
Cefepime | ≥ 64 | R | MIC | ≤ 2 | ≥ 16 |
Cefpodoxime | ≥ 8 | R | MIC | ≤ 2 | ≥ 8 |
Aztreonam | ≥ 64 | R | MIC | ≤ 4 | ≥ 16 |
Meropenem | ≥ 16 | R | MIC | ≤ 1 | ≥ 4 |
Imipenem | ≥ 16 | R | MIC | ≤ 1 | ≥ 4 |
Gentamicin | ≥ 16 | R | MIC | ≤ 4 | ≥ 16 |
Amikacin | ≥ 64 | R | MIC | ≤ 16 | ≥ 64 |
Ciprofloxacin | ≥ 2 | R | MIC | ≤ 0.25 | ≥ 1 |
Levofloxacin | 0.25 | S | MIC | ≤ 0.5 | ≥ 2 |
Moxifloxacin | 1 | S | MIC | ≤ 1 | ≥ 4 |
Cotrimoxazole | ≥ 16 | R | MIC | ≤ 2 | ≥ 4 |
Polymyxin B | 1 | S | MIC | ≤ 1 | ≥ 4 |
Tetracycline | 4 | S | MIC | ≤ 4 | ≥ 16 |
Tigecycline | 2 | S | MIC | ≤ 2 | ≥ 8 |
- Citation: Wang TH, Zhao JC, Huang B, Wang JR, Yuan D. Successful endovascular treatment with long-term antibiotic therapy for infectious pseudoaneurysm due to Klebsiella pneumoniae: A case report. World J Clin Cases 2020; 8(24): 6529-6536
- URL: https://www.wjgnet.com/2307-8960/full/v8/i24/6529.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i24.6529